Contrastive study of the tissue expression and serum concentration of pepsinogen C in gastric mucosa diseases

Chinese Journal of Cancer Research

Volumn 18, Issue 1, 2006, Pages 8-11

  Li, Hong Mei ^a,b   Ning, Pei Fang ^b   Yuan, Yuan ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

^b LIAONING CANCER HOSPITAL AND INSTITUTE   (China)

Author keywords

Expression; Gastric cancer; Pepsinogen A; Pepsinogen C; Serology

Indexed keywords

PEPSINOGEN; PEPSINOGEN II;

ADOLESCENT; ADULT; AGED; ARTICLE; ATROPHIC GASTRITIS; CANCER DIAGNOSIS; CANCER SCREENING; ENZYME BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PROTEIN EXPRESSION; STOMACH BIOPSY; STOMACH CANCER; STOMACH DISEASE; STOMACH MUCOSA; STOMACH ULCER;

EID: 33645739242     PISSN: 10009604     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11670-006-0008-y     Document Type: Article

References (23)

1. Lahner E, Caruana P, D'Ambra G, et al. First endoscopic-histologic follow-up in patients with body-predominant atrophic gastritis: when should it be done [J]? Gastrointest Endosc 2001; 53:443-8.
2. Conchillo JM, Houben G, de Bruine A, et al. Is type III intestinal metaplasia an obligatory precancerous lesion in intestinal-type gastric carcinoma [J]? Eur J Cancer Prev 2001; 10:307-12.
3. Moore SA, Sielecki AR, Chernaia MM, et al. Crystal and molecular structures of human progastricsin at 1.62 A resolution [J]. J Mol Biol 1995; 247: 466-85.
4. Fernandez R, Vizoso F, Rodriguez JC, et al. Expression and prognostic significance of pepsinogen C in gastric carcinoma [J]. Ann Surg Oncol 2000; 7:508-14.
5. Samloff IM. Pepsinogens I and II: Purification from gastric mucosa and radioimmunoassay in serum [J]. Gastroenterology 1982; 82:26-33.
6. Kageyama T, Ichinose M, Tsukada-Kato S, et al. Molecular cloning of neonate/infant specific pepsinogens from rat stomach mucosa and their expressional change during development [J]. Biochem Biophys Res Commun 2000; 267:806-12.
7. Ning PF, Sun LP, Liu HJ, et al. Expression of pepsinogen C in gastric cancer and its precursor [J]. Natl Med J China 2004; 84:818-21.
8. Filipe MI, Potet F, Bogomoletz WV, et al. Incomplete sulphmucin-secreting intestinal metaplasia for gastric cancer. Preliminary data from a prospective study from three centers [J]. Gut 1985; 26:1319-26.
9. Broutet N, Plebani M, Sakarovitch C, et al. Pepsinogen A, pepsinogen C, and gastrin as markers of atrophic chronic gastritis in European dyspeptics [J]. Br J Cancer 2003; 88:1239-47.
10. Whiting JL, Sigurdsson A, Rowlands DC, et al. The long term results of endoscopic surveillance of premalignant gastric lesions [J]. Gut 2002; 50: 378-81.
11. Kitahara F, Kobayashi K, Sato T, et al. Accuracy of screening for gastric cancer using serum pepsinogen concentrations [J]. Gut 1999; 44:693-7.
12. Nishizawa M, Shiga T, Hayashi M. Evaluation of serum pepsinogen test for screening gastric cancer [J]. Nippon Rinsho 2001; 4(Suppl):538-42.
13. Ley C, Mohar A, Guarner J, et al. Screening markers for chronic atrophic gastritis in Chiapas, Mexico [J]. Cancer Epidemiol Biomarkers Prev 2001; 10:107-12.
14. Dinis-Ribeiro M, da Costa-Pereira A, Lopes C, et al. Validity of serum pepsinogen I/II ratio for the diagnosis of gastric epithelial dysplasia and intestinal metaplasia during the follow-up of patients at risk for intestinal-type gastric adenocarcinoma [J]. Neoplasia 2004; 6:449-56.
15. Huang SC, Miki K, Furihata C, et al. Enzyme-linked immunosorbent assays for serum pepsinogens I and II using monoclonal antibodies-with data on peptic ulcer and gastric cancer [J]. Clin Chim Acta 1988; 175:37-50.
16. Scorilas A, Diamandis EP, Levesque MA, et al. Immunoenzymatically determined pepsinogen C concentration in breast tumor cytosols: an independent favorable prognostic factor in node-positive patients [J]. Clin Cancer Res 1999; 5:1778-85.
17. Serra C, Vizoso F, Lamelas ML, et al. Comparative study of two androgen-induced markers (apolipoprotein D and pepsinogen C) in female and male breast carcinoma [J]. Int J Surg Investig 2000; 2:183-92.
18. Merino AM, Vazquez J, Rodriguez JC, et al. Pepsinogen C expression in tumors of extragastric origin [J]. Int J Biol Markers 2001; 15:165-70.
19. Diaz M, Rodriguez JC, Sanchez J, et al. Clinical significance of pepsinogen C tumor expression in patients with stage D2 prostate carcinoma [J]. Int J Biol Markers 2002; 17:125-9.
20. Rojo JV, Merino AM, Gonzalez LO, et al. Expression and clinical significance of pepsinogen C in epithelial ovarian carcinomas [J]. Eur J Obstet Gynecol Reprod Biol 2002; 104:58-63.
21. Kodoi A, Yoshihara M, Sumii K, et al. Serum pepsinogen in screening for gastric cancer [J]. J Gastroenterol 1995; 30:452-60.
22. Suzuki H, Masaoka T, Hosoda H, et al. Plasma ghrelin concentration correlates with the levels of serum pepsinogen I and pepsinogen I/II ratio-a possible novel and non-invasive marker for gastric atrophy [J]. Hepatogastroenterology 2004; 51:1249-54.
23. Dinis-Ribeiro M, Lopes C, da Costa-Pereira A, et al. A follow up model for patients with atrophic chronic gastritis and intestinal metaplasia [J]. J Clin Pathol 2004; 57:177-82.